The emerging theme of LSD1 being a critical regulator of cancer stemness, corroborated both by basic research [27,28,29,30,31,32] and clinical studies associating its expression with aggressive and poorly differentiated tumors [25], prompted us to investigate more thoroughly its role in breast cancer stem cells. The gene discussed is KDM1A; the disease is breast cancer.